超低剖面Minos覆膜支架在标准与困难解剖腹主动脉瘤中的应用:一项多中心回顾性研究
该多中心回顾性研究在3个高容量中心纳入2020至2023年连续接受Minos覆膜支架行EVAR的90例腹主动脉瘤患者,辅助技术成功率为100%,平均随访14.2±9.6个月,无死亡,晚期再干预率为6.7%,困难与标准解剖的再干预率无显著差异。
要点
- 90例腹主动脉瘤患者使用超低剖面Minos覆膜支架行EVAR,辅助技术成功率为100%。
- 围手术期2例并发症需再干预:1例入路部位外科出血和1例髂支闭塞。
- 平均随访14.2±9.6个月无死亡,晚期再干预6例(6.7%),困难与标准解剖的再干预率无显著差异。
核心结论
- Minos覆膜支架在治疗困难解剖和标准解剖的腹主动脉瘤中安全有效,其结果为平均随访14个月时所维持。
- 需要更大的样本量和更长的随访来评估更长期的结果。
研究设计与样本
- 回顾性研究,在3个高容量血管外科中心回顾性审查前瞻性维护的数据库,收集2020至2023年间连续使用Minos覆膜支架行EVAR的所有病例。
- 共90例患者接受Minos覆膜支架行EVAR,记录患者临床和手术数据、围手术期及术后结局。
主要发现
- 辅助技术成功率为100%,共6例计划外辅助手术。
- 2例围手术期并发症需再干预:1例入路部位外科出血和1例髂支闭塞。
- 所有计划外辅助手术和早期再干预(7例患者共8次)均发生在困难髂动脉或狭窄分叉的腹主动脉瘤中。
- 平均随访14.2±9.6个月,无死亡,所有患者完成计划监测方案。
- 晚期再干预6例(6.7%):2例IA型内漏、1例IB型内漏、1例II型内漏和2例髂支闭塞;困难解剖与标准解剖动脉瘤的再干预率无显著差异。
局限性
- 需要更大的样本量和更长的随访来评估更长期的结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Narrow and tortuous iliac axes are the second most common reason the feasibility of endovascular aortic repair (EVAR), and low-profile endografts were conceived to overcome the limitation of narrow and tortuous iliac axes. This study aims to report the initial results of EVAR performed with the ultra-low-profile Minos® abdominal endograft through a retrospective study conducted across 3 high-volume centers. METHODS: We retrospectively reviewed a prospectively maintained database collecting all consecutive EVAR performed with the Minos endograft across 3 Centers of Vascular Surgery between 2020 and 2023. Patients' clinical and operative data, perioperative, and postoperative outcomes were recorded. RESULTS: Ninety patients received EVAR with the Minos endograft. Assisted technical success was 100%, with 6 unplanned adjunctive procedures. Two perioperative complications required reinterventions: 1 access site surgical bleeding and an iliac limb occlusion. All unplanned adjunctive procedures and early reinterventions (8 in 7 patients) occurred in abdominal aortic aneurysms with hostile iliac arteries or narrow carrefour. Over a mean follow-up of 14.2 ± 9.6 months, no deaths were observed, and all patients completed the scheduled surveillance protocol. Late reinterventions were 6 (6.7%): 2 type IA endoleaks (ELs), 1 type IB EL, 1 type II EL, and 2 limb occlusions. There was no significant difference in reintervention rates between aneurysms with hostile and standard anatomy. CONCLUSIONS: The Minos endograft is safe and effective in treating aneurysms with hostile and standard anatomy, and its results are maintained at a mean follow-up of 14 months. A larger sample size and a longer follow-up are necessary to assess the results on the longer term.
引用
- Marone EM, Cognolato D, Perkmann R, et al. The Ultra-Low-Profile Minos Endograft in Abdominal Aortic Aneurysms with Standard and Hostile Anatomy. A Multicenter Retrospective Study. Ann Vasc Surg. 2024. PMID: 39025219. doi:10.1016/j.avsg.2024.05.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。